The Battle against “Silent” Liver Disease
Early detection, monitoring, and noninvasive diagnostic testing are essential to controlling this epidemic.
Read MorePosted by Laurie Bonner | Mar 26, 2021 | Disease States |
Early detection, monitoring, and noninvasive diagnostic testing are essential to controlling this epidemic.
Read MorePosted by Melanie Hamilton-Basich | Feb 25, 2021 | Prenatal Testing |
The method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.
Read MorePosted by Melanie Hamilton-Basich | Feb 18, 2021 | Hematology & Serology, Research |
New research has shown that results of blood tests routinely performed by GPs everywhere contain a hidden fingerprint that can identify people silently developing potentially fatal liver cirrhosis.
Read MorePosted by Melanie Hamilton-Basich | Dec 7, 2020 | Diabetes & Metabolic Diseases, Prenatal Testing, Research |
A new study outlines a role for pregnancy-associated plasma protein A in gestational diabetes, with potential as a diagnostic tool and therapeutic target.
Read MorePosted by Melanie Hamilton-Basich | Aug 15, 2020 | Diabetes & Metabolic Diseases |
A study suggests the hemoglobin A1c test can identify youth at high risk of developing type 2 diabetes and associated cardiovascular problems.
Read More